Annabell Szymansky

902 total citations
13 papers, 81 citations indexed

About

Annabell Szymansky is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Annabell Szymansky has authored 13 papers receiving a total of 81 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Neurology and 4 papers in Cancer Research. Recurrent topics in Annabell Szymansky's work include Neuroblastoma Research and Treatments (7 papers), Acute Lymphoblastic Leukemia research (3 papers) and Cancer Genomics and Diagnostics (3 papers). Annabell Szymansky is often cited by papers focused on Neuroblastoma Research and Treatments (7 papers), Acute Lymphoblastic Leukemia research (3 papers) and Cancer Genomics and Diagnostics (3 papers). Annabell Szymansky collaborates with scholars based in Germany, United States and Japan. Annabell Szymansky's co-authors include Anton G. Henssen, Angelika Eggert, Johannes H. Schulte, Richard P. Koche, Kerstin Haase, Renate Kirschner‐Schwabe, Marleen Seiler, Jana Hof, Kathy Astrahantseff and Kristina Althoff and has published in prestigious journals such as Blood, Cancer Research and Genome Research.

In The Last Decade

Annabell Szymansky

10 papers receiving 80 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annabell Szymansky Germany	6	39	25	20	19	12	13	81
Seiji Koishi Japan	8	81 2.1×	45 1.8×	23 1.1×	6 0.3×	8 0.7×	13	145
Quentin Campbell Hewson United Kingdom	6	41 1.1×	10 0.4×	3 0.1×	28 1.5×	8 0.7×	8	84
P. Hofmann Germany	6	38 1.0×	7 0.3×	4 0.2×	13 0.7×	6 0.5×	13	117
Stacy J. Hines‐Dowell United States	7	39 1.0×	26 1.0×	22 1.1×	8 0.4×	2 0.2×	10	156
Vida Chitsazzadeh United States	6	49 1.3×	16 0.6×	8 0.4×	3 0.2×	4 0.3×	10	103
Laurel Ball United States	5	45 1.2×	11 0.4×	6 0.3×	6 0.3×	4 0.3×	5	95
Resham Ejaz Canada	7	55 1.4×	4 0.2×	10 0.5×	13 0.7×	12 1.0×	16	132
Theresa Brunet Germany	7	54 1.4×	9 0.4×	2 0.1×	7 0.4×	8 0.7×	24	110
Matthew Gianferante United States	3	34 0.9×	23 0.9×	14 0.7×	58 3.1×		4	81
Kerry Wall United Kingdom	4	24 0.6×	40 1.6×	6 0.3×	9 0.5×	2 0.2×	5	62

Countries citing papers authored by Annabell Szymansky

Since Specialization

Citations

This map shows the geographic impact of Annabell Szymansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annabell Szymansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annabell Szymansky more than expected).

Fields of papers citing papers by Annabell Szymansky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annabell Szymansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annabell Szymansky. The network helps show where Annabell Szymansky may publish in the future.

Co-authorship network of co-authors of Annabell Szymansky

This figure shows the co-authorship network connecting the top 25 collaborators of Annabell Szymansky. A scholar is included among the top collaborators of Annabell Szymansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annabell Szymansky. Annabell Szymansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Szymansky, Annabell, Kathy Astrahantseff, Carolina Rosswog, et al.. (2025). Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma. Cancer Research Communications. 5(1). 167–177.

Giurgiu, Mădălina, Elias Rodríguez-Fos, Rocío Chamorro González, et al.. (2024). Reconstructing extrachromosomal DNA structural heterogeneity from long-read sequencing data using Decoil. Genome Research. 34(9). 1355–1364. 10 indexed citations

Thorwarth, Anne, Kathy Astrahantseff, Annabell Szymansky, et al.. (2024). Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma. Journal of Clinical Medicine. 13(19). 5995–5995. 1 indexed citations

González, Rocío Chamorro, Lotte Brückner, Thomas Conrad, et al.. (2024). Intercellular extrachromosomal DNA copy-number heterogeneity drives neuroblastoma cell state diversity. Cell Reports. 43(9). 114711–114711. 8 indexed citations

Sprüssel, Annika, Takayoshi Suzuki, Naoki Miyata, et al.. (2024). Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis. Journal of Clinical Medicine. 13(20). 6081–6081.

Rodríguez-Fos, Elias, Mercè Planas-Fèlix, Martin Burkert, et al.. (2023). Mutational topography reflects clinical neuroblastoma heterogeneity. Cell Genomics. 3(10). 100402–100402. 8 indexed citations

Hof, Jana, Stefanie Groeneveld‐Krentz, Annabell Szymansky, et al.. (2020). Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia. Blood. 135(12). 921–933. 17 indexed citations

Krumbholz, Manuela, Marion Fillies, Annabell Szymansky, et al.. (2019). High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6‐RUNX1‐positive acute lymphoblastic leukemia. Pediatric Blood & Cancer. 66(8). e27780–e27780. 11 indexed citations

Szymansky, Annabell, Heathcliff Dorado García, Joern Toedling, et al.. (2018). Preclinical evaluation of BET-bromodomain inhibitor TEN-010 as monotherapy and combination therapy in MYC-driven neuroblastoma. Annals of Oncology. 29. iii12–iii13. 1 indexed citations

10.

García, Heathcliff Dorado, Ian C. MacArthur, Koshi Imami, et al.. (2018). Abstract 2628: Synthetic lethal targeting of ATR in alternative lengthening of telomeres-dependent rhabdomyosarcoma. Cancer Research. 78(13_Supplement). 2628–2628. 1 indexed citations

11.

Timme, Natalie, Shuai Liu, Heathcliff Dorado García, et al.. (2018). Abstract 2624: Dual PLK1 and BRD4 inhibition has synergistic therapeutic effects against high-risk rhabdomyosarcoma. Cancer Research. 78(13_Supplement). 2624–2624. 1 indexed citations

12.

Henssen, Anton G., Andrea Odersky, Annabell Szymansky, et al.. (2016). Targeting tachykinin receptors in neuroblastoma. Oncotarget. 8(1). 430–443. 23 indexed citations

13.

Hof, Jana, Annabell Szymansky, Arend von Stackelberg, Cornelia Eckert, & Renate Kirschner‐Schwabe. (2014). Clinical Significance of NT5C2 Mutations in Children with First Relapse of B-Cell Precursor Acute Lymphoblastic Leukemia. Blood. 124(21). 3789–3789.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact